Rolf Larsson

13.4k total citations
306 papers, 10.2k citations indexed

About

Rolf Larsson is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Rolf Larsson has authored 306 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 157 papers in Molecular Biology, 107 papers in Oncology and 38 papers in Cancer Research. Recurrent topics in Rolf Larsson's work include Cancer therapeutics and mechanisms (32 papers), Peptidase Inhibition and Analysis (21 papers) and Acute Lymphoblastic Leukemia research (20 papers). Rolf Larsson is often cited by papers focused on Cancer therapeutics and mechanisms (32 papers), Peptidase Inhibition and Analysis (21 papers) and Acute Lymphoblastic Leukemia research (20 papers). Rolf Larsson collaborates with scholars based in Sweden, United States and Norway. Rolf Larsson's co-authors include Peter Nygren, Joachim Gullbo, Mårten Fryknäs, Bo Nilsson, Malin Wickström, Graciela Elgue, Olle Korsgren, Stig Linder, Linda Rickardson and Kristina Nilsson Ekdahl and has published in prestigious journals such as Nucleic Acids Research, Nature Medicine and Nature Communications.

In The Last Decade

Rolf Larsson

302 papers receiving 9.9k citations

Peers

Countries citing papers authored by Rolf Larsson

Since Specialization

Citations

This map shows the geographic impact of Rolf Larsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf Larsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf Larsson more than expected).

Fields of papers citing papers by Rolf Larsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolf Larsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf Larsson. The network helps show where Rolf Larsson may publish in the future.

Co-authorship network of co-authors of Rolf Larsson

This figure shows the co-authorship network connecting the top 25 collaborators of Rolf Larsson. A scholar is included among the top collaborators of Rolf Larsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolf Larsson. Rolf Larsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ex vivo drug responses and molecular profiles of 597 pediatric acute lymphoblastic leukemia patients 2025 ·HemaSphere ·(unknown), (unknown), Henrik Gezelius, Anders Lundmark, (unknown), Claes Andersson, Josefine Palle, Britt‐Marie Frost, Samppa Ryhänen, Trond Flægstad, Ólafur G. Jónsson, Kjeld Schmiegelow, Mats Heyman, Arja Harila‐Saari, Peter Nygren, Rolf Larsson, Gudmar Lönnerholm, Jessica Nordlund	0
2	Cell-lineage controlled epigenetic regulation in glioblastoma stem cells determines functionally distinct subgroups and predicts patient survival 2022 ·Nature Communications ·Xi Lu, (unknown), Malin Jarvius, (unknown), Yonglong Dang, (unknown), Yuan Xie, E‐Jean Tan, Pengwei Xing, Rolf Larsson, Mårten Fryknäs, Lene Uhrbom, Xingqi Chen	15
3	DNA Methylation Signatures Predict Cytogenetic Subtype and Outcome in Pediatric Acute Myeloid Leukemia (AML) 2021 ·Genes ·(unknown), Josefine Palle, Christofer Bäcklin, Jonas Abrahamsson, Ulrika Norén‐Nyström, Henrik Hasle, Kirsi Jahnukainen, Ólafur Gísli Jónsson, Randi Hovland, Birgitte Lausen, Rolf Larsson, Lars Palmqvist, Anna Staffas, Bernward Zeller, Jessica Nordlund	9
4	Mouse Models of Pediatric Supratentorial High-grade Glioma Reveal How Cell-of-Origin Influences Tumor Development and Phenotype 2016 ·Cancer Research ·Smitha Sreedharan, (unknown), Yuan Xie, Anders Sundström, Malin Jarvius, Sylwia Libard, Irina Alafuzoff, Holger Weishaupt, Mårten Fryknäs, Rolf Larsson, Fredrik J. Swartling, Lene Uhrbom	16
5	Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids 2016 ·Cell chemical biology ·Wojciech Senkowski, Malin Jarvius, Jenny Rubin, Johan Lengqvist, Mats G. Gustafsson, Peter Nygren, Kim Kultima, Rolf Larsson, Mårten Fryknäs	28
6	Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal Cancer 2015 ·Molecular Cancer Therapeutics ·Wojciech Senkowski, Xiaonan Zhang, Maria Hägg Olofsson, Ruben Isacson, Urban Höglund, Mats Gustafsson, Peter Nygren, Stig Linder, Rolf Larsson, Mårten Fryknäs	118
7	A Pragmatic Definition of Therapeutic Synergy Suitable for Clinically Relevant In Vitro Multicompound Analyses 2014 ·Molecular Cancer Therapeutics ·Muhammad Kashif, Claes Andersson, Magnus Åberg, Peter Nygren, Tobias Sjöblom, Ulf Hammerling, Rolf Larsson, Mats G. Gustafsson	16
8	AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and dose dependent reduction of tyrosine kinase activity in acute myeloid leukemia 2013 ·Biochemical Pharmacology ·Anna Eriksson, Antonia Kalushkova, Malin Jarvius, Riet Hilhorst, Linda Rickardson, Hanna Göransson Kultima, Rik de Wijn, (unknown), Mårten Fryknäs, Fredrik Öberg, Rolf Larsson, Vendela Parrow, Martin Höglund	12
9	Beneficial Effects of Coating Alginate Microcapsules with Macromolecular Heparin Conjugates– In Vitro and In Vivo Study 2013 ·Tissue Engineering Part A ·Vijayaganapathy Vaithilingam, Gabriela Kolláriková, Meirigeng Qi, Rolf Larsson, Igor Lacı́k, Kjetil Formo, Enza Marchese, José Oberholzer, Gilles J. Guillemin, Bernard E. Tuch	25
10	Haemocompatibility and ion exchange capability of nanocellulose polypyrrole membranes intended for blood purification 2012 ·Journal of The Royal Society Interface ·Natália Ferraz, Daniel O. Carlsson, Jaan Hong, Rolf Larsson, Bengt Fellström, Leif Nyholm, Maria Strømme, Albert Mihranyan	56
11	Sage components enhance cell death through nuclear factor kappa-B signaling 2011 ·Scopus ·Sally J. Deeb, Chirine El‐Baba, Saadia Hassan, Rolf Larsson, Hala Gali‐Muhtasib	2
12	In vitro evaluation of clinical activity and toxicity of anticancer drugs using tumor cells from patients and cells representing normal tissues 2011 ·Cancer Chemotherapy and Pharmacology ·Caroline Haglund, Anna Åleskog, Peter Nygren, Joachim Gullbo, Martin Höglund, Malin Wickström, Rolf Larsson, Elin Lindhagen	27
13	Nanoparticulate Quillaja saponin induces apoptosis in human leukemia cell lines with a high therapeutic index 2010 ·SHILAP Revista de lepidopterología ·Kefei Hu, (unknown), Rolf Larsson, et al., (unknown), (unknown), (unknown)	4
14	Alpha terpineol: A potential anticancer agent which acts through suppressing NF-κB signalling 2010 ·Scopus ·Saadia Hassan, Hala Gali‐Muhtasib, H. Göransson, Rolf Larsson	12
15	A New Method for Incorporating Functional Heparin onto the Surface of Islets of Langerhans 2008 ·Tissue Engineering Part C Methods ·(unknown), Torsten Eich, Javier Sánchez, Bo Nilsson, Olle Korsgren, Rolf Larsson	25
16	Cellular drug sensitivity in MLL-rearranged childhood acute leukemia is correlated to partner genes and cell lineage : On behalf of the Nordic Society for Paediatric Haematology and Oncology 2005 ·British Journal of Haematology ·Josefine Palle, Britt‐Marie Frost, Erik Forestier, Göran Gustafsson, Peter Nygren, Marit Hellebostad, Ólafur Gísli Jónsson, Jukka Kanerva, Kjeld Schmiegelow, Rolf Larsson, Gudmar Lönnerholm	1
17	CHS 828 Inhibits Neuroblastoma Growth in Mice Alone and in Combination with Antiangiogenic Drugs 2002 ·Pediatric Research ·(unknown), (unknown), (unknown), Rolf Larsson, Rolf Christofferson	20
18	A New Antibody Recognizing the vIII Mutation of Human Epidermal Growth Factor Receptor 2002 ·Tumor Biology ·(unknown), Lars Gedda, Göran Hesselager, Rolf Larsson, Monica Nistér, Torgny Stigbrand, Kenneth Wester, (unknown)	31
19	C3 Adsorbed to a Polymer Surface Can Form an Initiating Alternative Pathway Convertase 2002 ·The Journal of Immunology ·Jonas Andersson, Kristina Nilsson Ekdahl, Rolf Larsson, Ulf Nilsson, Bo Nilsson	116
20	Modulation of cell death and metabolic effects by 3-aminobenzamide in U-937 GTB cells exposed to CHS 828 2001 ·Biochemical Pharmacology ·Henrik Lövborg, (unknown), Joachim Gullbo, (unknown), Peter Nygren, Rolf Larsson	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact